ladiratuzumab vedotin (SGN-LIV1A) / Merck (MSD), Pfizer, Seagen  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ladiratuzumab vedotin (SGN-LIV1A) / Merck (MSD), Pfizer
LV-SPIND-001, NCT06362590: Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors

Available
N/A
NA
ladiratuzumab vedotin
Seagen Inc.
 
 

Download Options